Evidence map›Paper›PMID 31731473›Full record

ReviewNutrients2019

Role of Citrate in Pathophysiology and Medical Management of Bone Diseases.

Donatella Granchi, Nicola Baldini, Fabio Massimo Ulivieri, Renata Caudarella

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Citrate Transporter NaCT and Enamel Mineralization: TheInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Review
  9. Understanding Renal Tubular Function: Key Mechanisms, Clinical Relevance, and Comprehensive Urine Assessment.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  10. Article
  11. Review
  12. Evaluation ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Conditional expression of FumA inApplied and environmental microbiology · 2024
    Article
  16. Article
  17. Engineering metabolism to modulate immunity.Advanced drug delivery reviews · 2024
    Review
  18. Targeting Longevity GeneMetabolites · 2023
    Article
  19. NMR metabolomic modelling of age and lifespan: a multi-cohort analysis.medRxiv : the preprint server for health sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Donatella GranchiLaboratory for Orthopedic Pathophysiology and Regenerative Medicine, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy.ORCID 0000-0001-7225-0023
Nicola BaldiniLaboratory for Orthopedic Pathophysiology and Regenerative Medicine, IRCCS Istituto Ortopedico Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy.
Fabio Massimo UlivieriNuclear Medicine, Bone Metabolic Unit, IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F.Sforza 35, 20122 Milano, Italy.ORCID 0000-0003-1357-3425
Renata CaudarellaMaria Cecilia Hospital, GVM Care and Research, Via Corriera 1, 48033 Cotignola (RA), Italy.
Istituto Ortopedico Rizzoli · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMaria Cecilia Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Citrate is an intermediate in the "Tricarboxylic Acid Cycle" and is used by all aerobic organisms to produce usable chemical energy. It is a derivative of citric acid, a weak organic acid which can be introduced with diet since it naturally exists in a variety of fruits and vegetables, and can be consumed as a dietary supplement. The close association between this compound and bone was pointed out for the first time by Dickens in 1941, who showed that approximately 90% of the citrate bulk of the human body resides in mineralised tissues. Since then, the number of published articles has increased exponentially, and considerable progress in understanding how citrate is involved in bone metabolism has been made. This review summarises current knowledge regarding the role of citrate in the pathophysiology and medical management of bone disorders.

Indexed as

Bone and BonesBone DiseasesCitric AcidHumansCitric Acidbone metabolismbone mineral densitybone remodellingcitrate supplementkidney diseasesosteopeniaosteoporosis

Identifiers

PMID31731473
PMCPMC6893553
OpenAlexW2981893683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.